Related Experiment Video
Updated: Feb 7, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer
Hong-Bao Shao1, Kewei Ren2, Sheng-Lin Gao3
1Department of Urology, Third Affiliated Hospital of Nantong University, Wuxi 214041, China.
Background/Aims:
Previous results on the association between MTR gene A2756G polymorphism and PCa risk are inconclusive.
Methods:
We used odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs) to evaluate the correlation between MTR A2756G polymorphism and risk of PCa in meta-analysis. Serum expression of MTR was detected by ELISA and in-silico tools were utilized to assess this variant.
Results:
Our study included 2,921 PCa patients and 3,095 control subjects. The results indicated that the MTR A2756G polymorphism is linked with an increased risk of PCa using three genetic models (G-allele vs. A-allele: OR = 1.16, 95%CI = 1.04 - 1.30; GA vs. AA: OR = 1.17, 95%CI = 1.02 - 1.33; GG+GA vs. AA: OR = 1.18, 95%CI = 1.04 - 1.34). Stratified analysis produced similar results. A significant association was also indicated in advanced PCa from the meta-analysis. Finally, our experiments showed evidence that serum MTR levels in PCa patients with AA genotypes were statistically higher than in those with GG/GA genotypes.
Conclusions:
Our present study suggests that the MTR A2756G polymorphism may contribute to the risk of developing PCa, particularly in Asian and hospital-based studies. Moreover, serum MTR might be utilized in diagnosis of PCa.
Insights
The MTR gene A2756G polymorphism is associated with an increased risk of prostate cancer (PCa). Higher serum MTR levels were observed in PCa patients with specific genotypes, suggesting a potential diagnostic role.
Area of Science:
- Genetics and Cancer Research
- Molecular Biology
- Epidemiology
Background:
- Previous studies on the association between the MTR gene A2756G polymorphism and prostate cancer (PCa) risk have yielded inconclusive results.
- Understanding genetic predispositions is crucial for PCa risk assessment and early detection.
Purpose of the Study:
- To evaluate the correlation between the MTR A2756G polymorphism and PCa risk using a comprehensive meta-analysis.
- To investigate the potential role of serum MTR levels in PCa diagnosis.
Main Methods:
- A meta-analysis was conducted using odds ratios (ORs) and 95% confidence intervals (95% CIs) to assess the MTR A2756G polymorphism and PCa risk.
- Serum MTR expression was measured using ELISA, and in-silico tools were employed to analyze the variant.
- The study included 2,921 PCa patients and 3,095 control subjects.
Main Results:
- The MTR A2756G polymorphism was significantly linked to an increased risk of PCa across three genetic models.
- Stratified analyses and advanced PCa subgroup analysis corroborated these findings.
- Serum MTR levels were statistically higher in PCa patients with AA genotypes compared to those with GG/GA genotypes.
Conclusions:
- The MTR A2756G polymorphism may contribute to PCa risk, especially in Asian and hospital-based populations.
- Serum MTR levels show potential as a biomarker for PCa diagnosis.
Related Concept Videos
ATP Synthase: Structure
ATP Synthase: Mechanism
Increasing Function
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Single Nucleotide Polymorphisms-SNPs
Increased Body Temperature

